Naohiro Mitsutakke, PhD

Institute for Health Economics and Policy, Japan

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-456) Reduction in the incidence of chronic hepatitis C, liver cancer, and related healthcare burden following the introduction of interferon-free direct-acting antiviral therapy in Japan: a national claims database study
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT